Literature DB >> 24832853

SCCmec types and pvl gene in methicillin-resistant Staphylococcus aureus strains from children hospitalized in a tertiary care hospital in Mexico.

Eunice Mireya Borbón-Esquer1, Alberto Villaseñor-Sierra, Erika Martínez-López, Juan José Jáuregui-Lomeli, Rosa Villaseñor-Martínez, Mariana Del Rocío Ruiz-Briseño.   

Abstract

BACKGROUND: The aim of this study was to determine the prevalence, SCCmec types, presence of the Panton-Valentine leukocidin (PVL) gene, and susceptibility to antibiotics of methicillin-resistant Staphylococcus aureus (MRSA) strains isolated from hospitalized children.
METHODS: From August 2009 to September 2011, 291 S. aureus strains were isolated from normally sterile body sites, of which 190 (65%) were MRSA. One hundred and two of the MRSA strains were genetically evaluated. SCCmec genotypes were identified by M-PCR and the PVL gene (pvl) by end-point PCR. Resistance to erythromycin, rifampicin, clindamycin, and trimethoprim-sulfamethoxazole (SXT) was assessed by Kirby-Bauer disk diffusion method in accordance with the Clinical and Laboratory Standards Institute guidelines of 2012.
RESULTS: Of the 102 strains evaluated, 97 (95%) were SCCmec type II, 5 (5%) were SCCmec type IVa, and all (100%) were pvl-negative. Resistance to erythromycin, clindamycin, rifampicin, and SXT was 97%, 95%, 0%, and 0%, respectively.
CONCLUSIONS: The prevalence of hospital-acquired MRSA was high. SCCmec type II was predominant and the pvl gene appeared not to play any role in the virulence of the MRSA strains from hospitalized children.

Entities:  

Keywords:  Methicillin-resistant Staphylococcus aureus; hospitalized child; molecular typing

Mesh:

Substances:

Year:  2014        PMID: 24832853     DOI: 10.3109/00365548.2014.912349

Source DB:  PubMed          Journal:  Scand J Infect Dis        ISSN: 0036-5548


  1 in total

1.  Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening.

Authors:  Vicenta Cázares-Domínguez; Ariadnna Cruz-Córdova; Sara A Ochoa; Gerardo Escalona; José Arellano-Galindo; Alejandra Rodríguez-Leviz; Rigoberto Hernández-Castro; Edgar O López-Villegas; Juan Xicohtencatl-Cortes
Journal:  PLoS One       Date:  2015-03-20       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.